Ibandronate (boniva) offers new options for osteoporosis.
Kessenich
Cathy R
CR
Department of Nursing, University of Tampa, Tampa, FL, USA.
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004164:Diphosphonates / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D007262:Infusions, Intravenous; D007408:Intestinal Absorption; D008657:Metabolic Clearance Rate; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000453:epidemiology; D018579:Patient Selection; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077557:Ibandronic Acid